These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31236688)

  • 1. UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications.
    Cabrera D; Arab JP; Arrese M
    Handb Exp Pharmacol; 2019; 256():237-264. PubMed ID: 31236688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
    Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
    Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile Acids in Cholestasis and its Treatment.
    Arab JP; Cabrera D; Arrese M
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s53-s57. PubMed ID: 29080340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid.
    Piazza F; Montagnani M; Russo C; Azzaroli F; Aldini R; Roda E; Roda A
    Dig Liver Dis; 2000 May; 32(4):318-28. PubMed ID: 11515630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile Acids in Cholestasis and its Treatment.
    Pablo Arab J; Cabrera D; Arrese M
    Ann Hepatol; 2017 Nov; 16 Suppl 1():S53-S57. PubMed ID: 31196636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
    Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
    Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile Acids as Signaling Molecules: Role of Ursodeoxycholic Acid in Cholestatic Liver Disease.
    Cifuentes-Silva E; Cabello-Verrugio C
    Curr Protein Pept Sci; 2024; 25(3):206-214. PubMed ID: 37594109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microtubule-independent choleresis and anti-cholestatic action of tauroursodeoxycholate in colchicine-treated rat liver.
    Nakai T; Katagiri K; Hoshino M; Hayakawa T; Ohiwa T
    Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):613-7. PubMed ID: 1361125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes.
    Mališová L; Kováčová Z; Koc M; Kračmerová J; Stich V; Rossmeislová L
    PLoS One; 2013; 8(12):e82086. PubMed ID: 24312631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bile acid TUDCA and neurodegenerative disorders: An overview.
    Zangerolamo L; Vettorazzi JF; Rosa LRO; Carneiro EM; Barbosa HCL
    Life Sci; 2021 May; 272():119252. PubMed ID: 33636170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
    Purucker E; Marschall HU; Winograd R; Matern S
    Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1.
    Pusl T; Vennegeerts T; Wimmer R; Denk GU; Beuers U; Rust C
    Biochem Biophys Res Commun; 2008 Feb; 367(1):208-12. PubMed ID: 18164257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis.
    Beuers U; Nathanson MH; Isales CM; Boyer JL
    J Clin Invest; 1993 Dec; 92(6):2984-93. PubMed ID: 8254052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
    Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tauroursodeoxycholate-Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives.
    Kusaczuk M
    Cells; 2019 Nov; 8(12):. PubMed ID: 31757001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts.
    Marzioni M; Francis H; Benedetti A; Ueno Y; Fava G; Venter J; Reichenbach R; Mancino MG; Summers R; Alpini G; Glaser S
    Am J Pathol; 2006 Feb; 168(2):398-409. PubMed ID: 16436655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice.
    Krones E; Eller K; Pollheimer MJ; Racedo S; Kirsch AH; Frauscher B; Wahlström A; Ståhlman M; Trauner M; Grahammer F; Huber TB; Wagner K; Rosenkranz AR; Marschall HU; Fickert P
    J Hepatol; 2017 Jul; 67(1):110-119. PubMed ID: 28242240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid.
    Thérien A; Cieślak A; Verreault M; Perreault M; Trottier J; Gobeil S; Vohl MC; Barbier O
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver Diseases.
    Halilbasic E; Steinacher D; Trauner M
    Dig Dis; 2017; 35(3):288-292. PubMed ID: 28249255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver.
    Beuers U; Bilzer M; Chittattu A; Kullak-Ublick GA; Keppler D; Paumgartner G; Dombrowski F
    Hepatology; 2001 May; 33(5):1206-16. PubMed ID: 11343250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.